Evidence map›Paper›PMID 31399627›Full record

ArticleScientific reports2019

Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs.

Ana Cadete, Ana Olivera, Magnus Besev, Pradeep K Dhal, Lídia Gonçalves, António J Almeida, Guillaume Bastiat, Jean-Pierre Benoit, María de la Fuente, Marcos Garcia-Fuentes and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Dextran Nanocapsules withPharmaceutics · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ana CadeteNanobiofar Group, IDIS, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Ana OliveraNanobiofar Group, IDIS, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Magnus BesevSanofi-Global R&D, Sanofi US, Waltham, USA.
Pradeep K DhalSanofi-Global R&D, Sanofi US, Waltham, USA.
Lídia GonçalvesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-6799-2740
António J AlmeidaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Guillaume BastiatMicro et Nanomedecines Translationnelles, MINT, Université Angers, INSERM 1066, CNRS 6021, 4 rue Larrey, Angers, France.
Jean-Pierre BenoitMicro et Nanomedecines Translationnelles, MINT, Université Angers, INSERM 1066, CNRS 6021, 4 rue Larrey, Angers, France.
María de la FuenteNano-Oncology Unit, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, Santiago de Compostela, Spain.
Marcos Garcia-FuentesNanobiofar Group, IDIS, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-6393-6469
María José AlonsoNanobiofar Group, IDIS, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Dolores TorresDepartment of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain. dolores.torres@usc.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preparation of sophisticated delivery systems for nanomedicine applications generally involve multi-step procedures using organic solvents. In this study, we have developed a simple self-assembling process to prepare docetaxel-loaded hyaluronic acid (HA) nanocapsules by using a self-emulsification process without the need of organic solvents, heat or high shear forces. These nanocapsules, which comprise an oily core and a shell consisting of an assembly of surfactants and hydrophobically modified HA, have a mean size of 130 nm, a zeta potential of -20 mV, and exhibit high docetaxel encapsulation efficiency. The nanocapsules exhibited an adequate stability in plasma. Furthermore, in vitro studies performed using A549 lung cancer cells, showed effective intracellular delivery of docetaxel. On the other hand, blank nanocapsules showed very low cytotoxicity. Overall, these results highlight the potential of self-emulsifying HA nanocapsules for intracellular drug delivery.

Indexed as

A549 CellsAntineoplastic AgentsDocetaxelDrug Delivery SystemsHumansHyaluronic AcidLung NeoplasmsNanocapsulesSurface-Active AgentsAntineoplastic AgentsDocetaxelHyaluronic AcidNanocapsulesSurface-Active Agents

Identifiers

PMID31399627
PMCPMC6689112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.